- Alawneh JA, Jones PS, Mikkelsen IK, Cho TH, Siemonsen S, Mouridsen K, Ribe L, Morris RS, Hjort N, Antoun N, Gillard JH, Fiehler J, Nighoghossian N, Warburton EA, Ostergaard L, Baron JC. Infarction of 'non-core-nonpenumbral' tissue after stroke: multivariate modelling of clinical impact. Brain 2011; 134: 1765-76
- Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell A, Du M-Q, Altmann DR, Thompson AJ,Compston DAS, Scott MA, Miller DH, Chandran S. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurology 2012; 11: 150-156
- Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA. The natural history of treated Parkinson's Disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 2011; 82:1112-8
- Ghosh BC, Calder AJ, Peers PV, Lawrence AD, Acosta-Cabronero J, Pereira JM, Hodges JR, Rowe JB. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 2012; 135: 2089-102
- Hughes LE, Nestor PJ, Hodges JR, Rowe JB. Magnetoencephalography of frontotemporal dementia:spatiotemporally localized changes during semantic decisions. Brain 2011; 134: 2513-22
- Kuan W-L, Poole E, Fletcher M, Karniely S, Tyers P, Wills M, Barker RA*, Sinclair JH*. A novel neuroprotective therapy for Parkinson's disease using a viral non-coding RNA that protects mitochondrial Complex I activity. J Exp Med 2012; 209: 1-10 (*equal last author)
- Moustafa RR, Momjian-Mayor I, Jones PS, Morbelli S, Day DJ, Aigbirhio FI, Fryer TD, Warburton EA, Baron JC. Microembolism vs Hemodynamic Impairment in Rosary-like Deep Watershed Infarcts: A combined PET and TCD study. Stroke 2011; 42: 3138-43
- Newcombe VF, Outtrim JG, Chatfield DA, Manktelow A, Hutchinson PJ, Coles JP, Williams GB, Sahakian BJ, Menon DK. Parcellating the neuroanatomical basis of impaired decision-making in traumatic brain injury. Brain 2011;134: 759-68
- Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-9
- Timofeev I, Carpenter KL, Nortje J, Al-Rawi PG, O'Connell MT, Czosnyka M, Smielewski P, Pickard JD, Menon DK, Kirkpatrick PJ, Gupta AK, Hutchinson PJ. Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain 2011; 134: 484-94
Rightnav:
Highlights
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
A link
